Astavri t1_ixwrjyp wrote
Reply to comment by GratefulOctopus in A novel medication for hemophilia B has just been approved by the Food and Drug Administration. The treatment is a form of gene therapy, intended to replace a dysfunctional gene that leaves people unable to control their bleeding. by Sariel007
Besides research or development, there is the manufacturing fixed costs. But research and development has their own fixed costs in process development to get it to the commercial level. Clinical trials are not cheap either.
Basically think of it this way. A machine is going to cost 100 million and it only makes 100 doses per year because that's how many people need it. This is just an abstract number to show the concept.
On the plus side, the alternatives are very expensive as well and you need to take them repeatedly, whereas this is a possibly a cure IIRC.
Viewing a single comment thread. View all comments